Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (6), 1108-1116
- https://doi.org/10.1067/mai.2000.105711
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Asthma control during long term treatment with regular inhaled salbutamol and salmeterolThorax, 1998
- The complementary role of glucocorticosteroids and long‐acting β‐adrenergic agonistsAllergy, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover studyBMJ, 1997
- Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.American Journal of Respiratory and Critical Care Medicine, 1996
- Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.Journal of Clinical Investigation, 1995
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Regulation of β-Adrenergic Receptors by Steroid HormonesAnnual Review of Physiology, 1984